Skip to main content

Oncology Central is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • News
  • Events coverage
  • Features
    • Opinion
    • Journal articles
    • Events calendar
    • Spotlights
    • In Focus

    Follow us on social media

  • Our Journals
  • Topic
    • Prevention, detection and screening
      • Biomarkers
      • Diagnostics
      • Epidemiology
      • Genetics & genomics
      • Prevention & screening
    • Bench to bedside
      • Cancer biology
      • Clinical trials
      • Drug approvals
      • Drug development
      • Emerging technologies
      • Industry & business
      • Preclinical research
    • Treatments
      • Chemotherapy
      • Immuno-oncology
      • Personalized & precision medicine
      • Radiology
      • Surgery
      • Targeted therapies
    • Supportive oncology
      • Palliative care
      • Patient perspectives
      • Quality of life
      • Survivorship
      • Virtual healthcare

    Follow us on social media

  • Disease specialty
    • Breast
    • Colorectal
    • Endocrine
    • Gastrointestinal
    • Genitourinary
    • Gynecologic
    • Head & neck
    • Hematologic
    • Hepatic
    • Lung
    • Neurologic
    • Pancreatic
    • Prostate
    • Rare tumors
    • Renal
    • Skin

    Follow us on social media

  • Multimedia
    • Videos
    • Podcasts
    • Infographics
    • Webinars
    • Downloadable eBooks

    Follow us on social media

  • Register
[COFFEE CHAT] The emotional and psychological impact of hepatocellular carcinoma on patients, families and caregivers WATCH NOW

Head and neck

Common locations of head and neck cancer are the nasal cavity, oral cavity, salivary gland, pharynx and larynx.

View more
Cancers that are known collectively as head and neck cancers usually begin in the squamous cells that line the mucosal surfaces of the head and neck. These cancers are referred to as squamous cell carcinomas of the head and neck.

Risk factors for head and neck cancer are smoking, alcohol consumption, salty foods, poor oral health, genetic factors, exposure to radiation and the HPV virus.

Head and neck cancer can be divided into seven stages. Stage 0 is where there are no cancer cells present in nearby structures or deep tissue and there are no cancer cells in the lymph nodes. Stage I is the same as previous with a primary tumor width of 2cm as is Stage II with a primary tumor width of 2–4cm. Stage III is where there are cancer cells present in the lymph nodes and the primary tumor width is less than 4cm and there are no cancer cells present in nearby structures, lymph nodes or distal sites. Stage IVA is where the primary tumor width is any size and cancer cells may be found in two or more lymph nodes and the tumor has grown into deeper tissue and nearby structures. The penultimate stage is Stage IVB whereby cancer cells may be found in one or more lymph nodes and are less than 6 cm. Stage IVC encompasses all of the above and is where the cancer cells have spread to distal sites.

Symptoms of head and neck cancer include persistently block sinuses, swelling of the jaw, jawbone or lining of the mouth, difficulty in breathing/ speaking as well as hearing problems – to name a few.

  • About
  • Accessibility
  • Advertising & Sponsorship
  • Contact Us
  • Editorial Policies
  • Expert Panel
  • Journals
  • Permissions and content ownership policy
  • Press release policy
  • Whitelist emails

Contact

Contact Us

Office info

Oncology Central is powered by Taylor & Francis Group

Oncology Central, 2-4 Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom
  • Taylor & Francis Group
  • Cookie Policy
  • Privacy Policy
  • Terms & Conditions
  • © 2026 Oncology Central